Literature DB >> 11101036

Induction of follicular wave emergence for estrus synchronization and artificial insemination in heifers.

M F Martinez1, G P Adams, J P Kastelic, D R Bergfel, R J Mapletoft.   

Abstract

The objective was to synchronize follicular wave emergence among cattle for synchronization of estrus and ovulation, and to determine pregnancy rate after AI at observed estrus. At random stages of the estrous cycle, a controlled internal drug release device (CIDR-B) was inserted intravaginally (Day 0) in 67 cross-bred beef heifers, and they were randomly allocated to receive either no further treatment (Control; n = 18); 5 mg of estradiol-17beta and 100 mg of progesterone im (E/P; n = 16); 100 microg im of GnRH (GnRH; n = 16); or transvaginal ultrasound-guided follicular ablation of all follicles > or = 5 mm (FA; n = 17). All heifers received a luteolytic dose of PGF (repeated 12 h later), and CIDR-B were removed on Days 9, 8, 6 or 5, in Control, E/P, GnRH or FA groups, respectively, so the dominant follicle of the induced wave was exposed to exogenous progesterone for a similar period of time in each group. Mean (+/- SEM) intervals (and range, in days) from treatment to follicular wave emergence in these groups were 3.5 +/- 0.6 (-2 to 8), 3.4 +/- 0.1 (3 to 4), 1.5 +/- 0.3 (-1 to 4), and 1.0 +/- 0.1 (0 to 2), respectively. Although the interval was longest (P<0.01) in the E/P and Control groups, it was least variable (P<0.01) in the E/P and FA groups. Intervals (and range, in days) from CIDR-B removal (and first PGF treatment) to estrus were 2.3 +/- 0.2 (1.5 to 4.5), 2.2 +/- 0.2 (1.5 to 3.0), 2.1 +/- 0.1,(1.5 to 3.5), and 2.5 +/- 0.1 (2.0 to 3.5), and to ovulation were 3.5 +/- 0.2 (2.5 to 5.5), 3.4 +/- 0.1 (3.0 to 4.5), 3.5 +/- 0.1 (2.5 to 4.5), and 3.8 +/- 0.1 (3.0 to 4.5), for Control, E/P, GnRH and FA groups, respectively (ns). The proportion of heifers displaying estrus was higher in the Control than in the FA group (94% versus 65%, P<0.05) and intermediate in EP and GnRH groups (87% and 75%). Heifers were inseminated approximately 12 h prior to ovulation (based on estrous behavior and ultrasound examinations). Pregnancy rates were 78%, 80%, 69% and 65% for Control, E/P, GnRH and FA groups, respectively (P=0.73). Results support the hypothesis that synchronous follicular wave emergence results in synchronous follicle development and, following progesterone removal, synchronous estrus and ovulation with high pregnancy rates to AI. The synchrony of estrus and ovulation in the E/P, GnRH and FA groups suggest that these treatments, in combination with CIDR-B, could be adapted to fixed-time insemination programs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101036     DOI: 10.1016/s0093-691x(00)00388-5

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  4 in total

1.  The effects of 3 gonadorelin products on luteinizing hormone release, ovulation, and follicular wave emergence in cattle.

Authors:  Marcelo Martínez; Reuben J Mapletoft; John P Kastelic; Terry Carruthers
Journal:  Can Vet J       Date:  2003-02       Impact factor: 1.008

2.  Treatments to Optimize the Use of Artificial Insemination and Reproductive Efficiency in Beef Cattle under Tropical Environments.

Authors:  Ocilon Gomes de Sá Filho; José Luiz Moraes Vasconcelos
Journal:  Vet Med Int       Date:  2010-11-08

3.  Synchronization of follicular wave emergence does not improve embryonic yield in superovulated ewes.

Authors:  Oscar Oliveira Brasil; Nathalia Hack Moreira; Fábia Fernanda Cardoso de Barros da Conceição; Paula Lorena Grangeira Souto; Cleidson Manoel Gomes da Silva; Alexandre Floriani Ramos
Journal:  Anim Reprod       Date:  2022-01-07       Impact factor: 1.807

4.  Aromatase inhibitor treatment with an intravaginal device and its effect on pre-ovulatory ovarian follicles in a bovine model.

Authors:  Jimena Yapura; Reuben J Mapletoft; Roger A Pierson; Jaswant Singh; Gregg P Adams
Journal:  Reprod Biol Endocrinol       Date:  2013-10-03       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.